Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Why Elanco (ELAN) Stock Is Trading Up Today

ELAN Cover Image

What Happened?

Shares of animal health company Elanco (NYSE: ELAN) jumped 2.2% in the afternoon session after the company announced its parasite protection product, Credelio Quattro, reached $100 million in net sales in less than eight months. This achievement makes the chewable tablet Elanco's fastest pet health product to achieve blockbuster status. Launched in January, Credelio Quattro protects dogs from fleas, ticks, heartworm disease, and three types of intestinal parasites. The product has rapidly gained traction, capturing approximately 14% of the dollar share in broad-spectrum sales from U.S. veterinary clinics by June. 

After the initial pop the shares cooled down to $18.93, up 2.7% from previous close.

Is now the time to buy Elanco? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Elanco’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 5 days ago when the stock dropped 4.1% on the news that competitor Boehringer Ingelheim announced the U.S. launch of a new, advanced vaccine for swine. 

The new vaccine, INGELVAC CIRCOFLEX ® AD, is the first to combine two key antigens in a single dose, potentially creating a more effective product in the animal health market. This development introduces fresh competitive pressure for Elanco, which operates in the same livestock health space, sparking investor concern over potential impacts on its market share. The stock's decline also came amid broader market weakness, as U.S. markets had closed lower the previous day on concerns about tariffs and rising bond yields, adding to the negative sentiment.

Elanco is up 57.1% since the beginning of the year, and at $18.93 per share, has set a new 52-week high. Investors who bought $1,000 worth of Elanco’s shares 5 years ago would now be looking at an investment worth $673.49.

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.